Bayer Diabetes Care and Epilepsy Therapy Project aim to make disease management more convenient
Tapping into the growing interest in hand-held gaming and apps among both kids and adults, two healthcare companies have released software to help make the management of diabetes and epilepsy more convenient.
Bayer Diabetes Care (Tarrytown, NY) has introduced the DIDGET blood glucose monitor, for kids ages 4 to 14, which connects directly to the Nintendo DS and DS Lite gaming systems. Aimed at helping kids with diabetes better manage their treatment, the DIDGET awards points that can be used to unlock new game levels and customize their gaming experience. The meter will also connect to Bayer's soon-to-be-released DIDGET World, an online community where users will be able to "spend" the points they earn from consistent blood-glucose testing and create their own page.
The Epilepsy Therapy Project (Middleburg, VA) released their iPhone app, My Epilepsy Diary, which is now available through the App Store. Joining the pool of medical treatment apps available in the App Store, My Epilepsy Diary allows consumers with epilepsy to "track events and manage epilepsy and treatments together with their healthcare team," according to the Epilepsy Therapy Project. With the app, users are able to track their seizures, side effects or other issues, as well as record medications and dosages and receive text or email alerts reminding them to take their medication.
The app allows patients to email seizure activity reports and medical histories directly to their physicians, allowing healthcare professionals to improve patient treatment as they receive real-time data.
An estimated 186,300 people under the age of 20 in the United States have diabetes, and approximately three million Americans are affected by epilepsy.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.